about
Immune Mechanisms in Myelodysplastic SyndromePotential of epigenetic therapies in the management of solid tumorsAccurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkersHistones and their modifications in ovarian cancer - drivers of disease and therapeutic targets.The potential of panobinostat as a treatment option in patients with relapsed and refractory multiple myeloma.ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias.Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome PatientsMutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence.Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results.Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndromeLKB1 loss links serine metabolism to DNA methylation and tumorigenesis.Factors affecting the persistence of drug-induced reprogramming of the cancer methylome.DNA Hypomethylating Drugs in Cancer Therapy.Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine).DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastomaAt the tipping point for epigenetic therapies in cancer.ELMO3: a direct driver of cancer metastasis?A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation.HDAC7 is overexpressed in human diabetic islets and impairs insulin secretion in rat islets and clonal beta cells.RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.Depletion of ZBTB38 potentiates the effects of DNA demethylating agents in cancer cells via CDKN1C mRNA up-regulationRewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism
P2860
Q26744500-43C34071-C0D6-4E11-893D-8AF98006A51CQ26783134-964D0CBB-6FA2-4991-949C-4A40040A1A20Q28069856-C5B7F6DC-4BC7-4280-8F10-B2C9686A83EBQ33741828-40C138C5-BB17-403B-9954-A2BF800F03CFQ34602263-86B71438-594E-402C-9B27-ADCBE74D2AE6Q36213571-B03CE457-67B4-4236-928F-35646B4BC344Q36401117-4EAAA937-D340-4ABF-9925-30015F4022AAQ36627526-2A2CB367-01CA-4CB6-AC5C-58BB4122E5A7Q38542092-C75BEA79-E7AE-4314-9CA2-874C6E4EB77DQ38582589-63DE9C92-9847-4C15-8CDC-D99276A45923Q38724302-035EFB71-FE94-430E-905B-B93A8682290AQ38733837-D1D3B7AA-9837-49DB-A65A-CCE6A338660BQ38777889-BCD24E34-A3AC-4CB4-800B-C725837F0DB9Q38979940-94D4BED0-5BA4-4795-8C19-F1A2103A8C71Q40447596-85D5931B-20C5-48FF-9FA5-C95F7C249FE4Q40579130-DFA40B48-A8EB-4A05-8F1D-E7DD41649152Q41728555-7165EEBD-1CAE-47CE-A508-EC1BC725BA96Q42778979-4CE7AFE6-6E76-4F42-B51C-F6B9AF9BD204Q43207153-68A3E4DB-B876-4F9A-B254-4DCCB0FB6F5FQ47264910-2DACF7DD-4671-4F73-8130-3EAC502680C2Q51354616-E4D0B6BE-618C-4F4E-A469-B9EEC6ADDD3CQ52643951-1937D3ED-8AFD-475C-ACB1-943806A29A4AQ57476629-555E5C1B-E200-4F07-9204-FC50142FA989Q58788944-DD27AE8D-1C12-4556-B99D-F5614973B28C
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Predicting response to epigenetic therapy
@ast
Predicting response to epigenetic therapy
@en
Predicting response to epigenetic therapy
@nl
type
label
Predicting response to epigenetic therapy
@ast
Predicting response to epigenetic therapy
@en
Predicting response to epigenetic therapy
@nl
prefLabel
Predicting response to epigenetic therapy
@ast
Predicting response to epigenetic therapy
@en
Predicting response to epigenetic therapy
@nl
P2860
P3181
P356
P1476
Predicting response to epigenetic therapy
@en
P2093
Marianne B Treppendahl
P2860
P3181
P356
10.1172/JCI69737
P407
P577
2014-01-02T00:00:00Z